Brucine, an alkaloid closely related to strychnine, is most commonly found in the Strychnos nux-vomica tree. Brucine poisoning is rare, since it is usually ingested with strychnine, and strychnine is more toxic than brucine. In synthetic chemistry, it can be used as a tool for stereospecific chemical syntheses. Brucine can be detected and quantified using liquid chromatography-mass spectrometry. Historically, brucine was distinguished from strychnine by its reactivity toward chromic acid. Since brucine is a large chiral molecule, it has been used in chiral resolution. Fisher first reported its use as a resolving agent in 1899, and it was the first natural product used as an organocatalyst in a reaction resulting in a enantiomeric enrichment by Marckwald, in 1904. Its bromide salt has been used as the stationary phase in HPLC in order to selectively bind one of two anionic enantiomers. Brucine has also been used in fractional distillation in acetone in order to resolve dihydroxy fatty acids, as well as diarylcarbinols. Brucine intoxication occurs very rarely, since it is usually ingested with strychnine. Symptoms of brucine intoxication include muscle spasms, convulsions, rhabdomyolysis, and acute kidney injury. Brucine’s mechanism of action closely resembles that of strychnine. It acts as an antagonist at glycine receptors and paralyzes inhibitory neurons.